2023 Meeting of the Society for Glycobiology
November 5–8, 2023
Hilton Waikoloa Village Resort, on the big island of Hawaii

Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression

A large number of studies have found that abnormal glucose metabolism exists before the occurrence of many cancers, and abnormal glucose metabolism, as a key link in energy reprogramming, is closely related to the occurrence and development of cancer. The process of tumorigenesis is the process by which cancer cells acquire the ten hallmarks of tumors, and the process of tumor progression is the process by which cancer cells maintain the ten hallmarks of tumors. Therefore, studying the reprogramming of glucose metabolism is crucial for a comprehensive understanding of the mechanism of tumorigenesis and development, and can also bring new hope for the clinical treatment and diagnosis of cancer. CD BioGlyco can provide analysis services for the relationship between glucose metabolism reprogramming and cancer characteristics based on the MOPCGM platform.

What We Do

CD BioGlyco can provide analytics services on the interaction between glucose metabolism reprogramming and the top ten hallmarks of cancer, and provide customers with the best glucose metabolism reprogramming solutions. Our experienced teams of scientists, researchers, and technicians provide a fast turnaround, and high-quality services at competitive prices for worldwide customers. Our customers have direct access to our staff and prompt feedback on their inquiries. If you are interested in our services, please contact us for more details.

This service is for Research Use Only, not intended for any clinical use.

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.